Using NV1023 as the delivery vector, we demonstrate that a single injection of this attenuated, replication-competent virus into the primary tumor will induce expression of HSV1-tk in cancer cells invading lymph nodes that can be selectively imaged with [18F]FEAU PET. This evidence concerns the gene TKT and cancer.